Clinical evaluation of 1-(beta-dimethylaminoethoxy)-3-n-butylisoquinoline monohydrochloride as an antipruritic agent.
D000982:Antipruritics; D009657:North Carolina; D011537:Pruritus / Q000628:therapy*; D011803:Quinine / Q000627:therapeutic use*
D000982:Antipruritics; D011803:Quinine
PRURITUS/therapy; QUININE/therapeutic use